BIO-SOLUTIONS CORP. STATEMENTS OF CASH FLOW (USD $)	5 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Net loss	$ (567,877)	$ (427,988)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization expense - license		24,167
Common stock issued or accrued for services		251,050
Change in assets and liabilities
(Increase) in inventory		(4,125)
Increase in accounts payable and accrued expenses	93,920	60,846
Total adjustments	554,037	331,938
Net cash (used in) operating activities	(13,840)	(96,050)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible notes payable, net of repayments	8,000
Short-term loans, net of repayments	(518)	94,920
Short-term loans - related party, net of repayments		4,260
Proceeds from the sale of common stock	7,180
Net cash provided by financing activities	14,662	99,180
Effect of foreign currency	(807)	672
NET INCREASE IN CASH AND CASH EQUIVALENTS	15	3,802
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	33	4
CASH AND CASH EQUIVALENTS - END OF PERIOD		3,806
Cash paid during the period for:
Cash paid during the period for Interest		1,499
NONCASH OPERATING AND INVESTING ACTIVITIES:
Conversion of accounts payable to common stock	$ 39,919	$ 30,000